Last reviewed · How we verify

Spherule-derived coccidioidin

Nielsen BioSciences, Inc. · Phase 3 active Biologic

Spherule-derived coccidioidin is a Biologic drug developed by Nielsen BioSciences, Inc.. It is currently in Phase 3 development for Coccidioidomycosis prevention in individuals at high risk. Also known as: Coccidioidin SD (proposed trade name).

Spherule-derived coccidioidin is a vaccine derived from the spherules of the Coccidioides fungus, which stimulates an immune response against the fungus.

Spherule-derived coccidioidin is a vaccine derived from the spherules of the Coccidioides fungus, which stimulates an immune response against the fungus. Used for Coccidioidomycosis prevention in individuals at high risk.

At a glance

Generic nameSpherule-derived coccidioidin
Also known asCoccidioidin SD (proposed trade name)
SponsorNielsen BioSciences, Inc.
ModalityBiologic
Therapeutic areaInfectious Disease
PhasePhase 3

Mechanism of action

The vaccine works by introducing antigens from the Coccidioides fungus to the body, which triggers an immune response and helps the body to recognize and fight the fungus. This is particularly useful for individuals who are at high risk of contracting coccidioidomycosis, a fungal infection caused by the Coccidioides fungus.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Spherule-derived coccidioidin

What is Spherule-derived coccidioidin?

Spherule-derived coccidioidin is a Biologic drug developed by Nielsen BioSciences, Inc., indicated for Coccidioidomycosis prevention in individuals at high risk.

How does Spherule-derived coccidioidin work?

Spherule-derived coccidioidin is a vaccine derived from the spherules of the Coccidioides fungus, which stimulates an immune response against the fungus.

What is Spherule-derived coccidioidin used for?

Spherule-derived coccidioidin is indicated for Coccidioidomycosis prevention in individuals at high risk.

Who makes Spherule-derived coccidioidin?

Spherule-derived coccidioidin is developed by Nielsen BioSciences, Inc. (see full Nielsen BioSciences, Inc. pipeline at /company/nielsen-biosciences-inc).

Is Spherule-derived coccidioidin also known as anything else?

Spherule-derived coccidioidin is also known as Coccidioidin SD (proposed trade name).

What development phase is Spherule-derived coccidioidin in?

Spherule-derived coccidioidin is in Phase 3.

What are the side effects of Spherule-derived coccidioidin?

Common side effects of Spherule-derived coccidioidin include Local reaction at injection site.

Related